Impower Health, Inc.

Impower Health, Inc. focuses on developing mobility assessment technologies. Founded in 2021 and headquartered in Nebraska, US. In February 2026, Impower Health, Inc.

raise an undisclosed amount of pre-seed funding led by new investor Boomerang Ventures. Impower Health, Inc. specializes in mobility assessment technologies designed for rehabilitation clinicians and fitness trainers. Their core product offerings include the Gait Index software and Gait Tracker module, which transform standard treadmills into real-time gait labs.

These solutions capture precise, clinically meaningful movement metrics such as speed, stride length, and cadence without the need for wearables or cameras. The technology aims to address the limitations of current mobility assessments, which often rely on subjective visual evaluations, by providing objective, data-driven insights that enhance recovery, optimize performance, and support long-term independence. Impower Health serves a diverse clientele, including rehabilitation providers, fitness trainers, and treadmill manufacturers across North America and Europe, focusing on enhancing patient care and athletic performance in these markets. Impower Health generates revenue through direct partnerships and B2B transactions with rehabilitation centers, fitness facilities, and treadmill manufacturers.

Revenue is structured around the licensing of their proprietary software, Gait Index™, and the integration of their Gait Tracker™ module into existing treadmill products. Clients typically engage in agreements that may involve one-time licensing fees or subscription models for ongoing software access and support services. These transactions empower fitness trainers and rehabilitation therapists to leverage advanced analytics for improved mobility outcomes, thus enhancing their service offerings. Specific pricing plans for these products are tailored to align with the needs of the client base, ensuring that both end-users and services are optimized for effectiveness and value.

The company plans to utilize the February 2026 funding to support commercialization, strategic partnerships, and capital formation for its mobility diagnostics platform. Future growth initiatives will likely include the development and launch of new products, targeting expansion into additional markets including Europe and Asia by 2027.